Introducing CHOP OPEN!

We have launched our new and improved learning platform, CHOP OPEN. Learn more and register for free.

This seminar focuses on pediatric gastroenterology and was delivered in Salzburg, Austria, from May 12 – 18, 2019. The lectures are prepared by staff from Children's Hospital of Philadelphia (CHOP) in weeklong modules that are prepared in affiliation with the American Austrian Foundation's Open Medical Institute. The lectures of this seminar are presented in the order of the live event.

Pediatric GI Pathology

At the conclusion of this session, participants will understand the pathology of GI in pediatrics, distinguish between the different types of esophagitis, distinguish between different gastric diseases, and understand the histology of the GI tract.

Not All Foreign Bodies Are Created Equal

At the conclusion of this session, participants will be able to describe different types of foreign body ingestion in the pediatric population, discuss complications with an emphasis on magnets and lithium batteries ingestion, and discuss algorithms for treatment of various types of foreign body ingestions.

Eosinophilic Esophagitis and EOG

At the conclusion of this session, participants will be able to understand the history, pathophysiology, clinical presentation, diagnosis and therapy of EoE, understand the new AGREE recommendations, and understand possible future diagnostic techniques and therapies.

Cholestatic Liver Disease

At the conclusion of this session, participants will be able to understand cholestatic liver disease and biliary atresia, and understand the different types of therapies available for pruritus of cholestasis.

Pediatric IBD Etiology and Presentation

At the conclusion of this session, participants will be able to review the current incidence of pediatric IBD and its shifts to incidence and prevalence, review the complex etiology of IBD such as genomics and gut microbiome, and discuss the presentation of pediatric Crohn's disease, ulcerative colitis, and indeterminate colitis.

GI Bleeding

At the conclusion of this session, participants will be able to discuss the prevalence, etiology and management of GI bleeding, as well as preparation and necessary training for pediatric endoscopic hemostasis, and discuss the therapeutic techniques of injection, thermal methods, clipping including OVESCO and Hemospray®.

Metabolic and Autoimmune Liver Disease

At the conclusion of this session, participants will be able to understand the different therapies available for autoimmune liver disease, and understand the pathogenesis of autoimmune hepatitis (AIH) and sclerosing cholangitis.

Pediatric IBD: Therapeutic Approach

At the conclusion of this session, participants will be able to understand the therapy goals for IBD, distinguish the types of drugs prescribed for IBD and ulcerative colitis, and understand the diet suggested for IBD patients.

Pediatric Acute Liver Failure

At the conclusion of this session, participants will be able to understand the etiologies, risk factors and management of acute liver failure (ALF), and predict the outcomes of ALF.

Dysphagia Vomiting GERD

At the conclusion of this session, participants will be able to predict the etiologies of dysphagia, vomiting and GERD; understand the clinical features of dysphagia, vomiting and GERD; distinguish abnormal neurologic symptoms and exams; and understand CVS and GERD management.

The Role of Genetics and Immune Dysregulation in VEO-IBD

At the conclusion of this session, participants will be able to review definition and unique challenges of VEO-IBD, demonstrate that VEO-IBD is a different disease than older onset IBD, review the role of epithelial and immune regulated processes in VEO-IBD patients, and demonstrate a collaborative approach to care for these patients and application to older onset IBD.

Viral Hepatitis

At the conclusion of this session, participants will be able to understand the epidemiology of viral hepatitis, the different therapies available for hepatitis, the risk factors for HCV, and the treatment available for HCV.

Clostridium Difficile Infection

At the conclusion of this session, participants will be able to understand the epidemiology and treatment of C. Diff, and distinguish the difference between C. Diff and FMT.

Stomach and Upper Tract Disorders

At the conclusion of this session, participants will be able to understand the regulations of gastric secretions, distinguish between stomach and upper tract disorders, and understand the treatment and symptoms of stomach and upper tract disorders.

Endoscopic Stricture Therapy

At the conclusion of this session, participants will be able to review endoscopic techniques for achalasia and stricture therapy, review pediatric literature on endoscopic therapy of achalasia and IBD-related strictures, and review side effects of endoscopic achalasia and stricture therapy.

GI Polyps in Children

At the conclusion of this session, participants will be able to understand the clinical presentation of GI polyps, understand the classification of colon polyps, distinguish juvenile polyposis from other GI polyps, differentiate between different syndromes related to GI polyps, understand the polypectomy technique, and understand the potential complications of GI polyps.